Type 2 Diabetes FAQ
Type 2 Diabetes FAQ
This page answers only the practical questions: what a records review is for, what the assessment costs and how that is worked out, which documents to send, when travelling should be postponed, how payment is arranged, and how the plan continues once you are home. The clinical questions are answered by the other six pages.
What it costs, and how the figure is arrived at
The records review comes first and it is free. Reports sent ahead are read by a clinician without charge, and the written opinion — including whether a visit would add anything to the care you already receive — comes back before payment is discussed at all.
Where a visit is appropriate, the cost is the sum of what the assessment actually needs, and in type 2 diabetes those components are: consultation and history; HbA1c and the laboratory panel; urine albumin and filtration rate to describe the kidneys; a lipid panel; dilated eye screening with imaging; foot screening with sensation, vibration and pulses; a period of flash or continuous glucose monitoring where pattern is the question; ultrasound or further imaging where the picture needs it; insulin pump assessment and training where that is under consideration; and the medicines prescribed.
An itemised quotation is issued once the records show which of those apply, because a person whose screening is up to date and whose target is settled needs far less than someone being assessed for the first time. What this page will not do is put a number on the condition itself: costs are agreed in writing before travel is booked.
How long the visit takes
The length is set by what the assessment turns up, and it is stated in the written plan before anything is booked. An assessment built around consultation, laboratory testing, eye screening and foot screening is arranged as outpatient visits and fits into a short stay. Where a period of glucose monitoring is needed to see the pattern, or where insulin is being started or a pump is being set up, extra days are added for training and for the first adjustments.
Where a foot wound is already present, or where lower-limb arterial intervention is being considered with our colleagues in other specialties, the timetable follows what that requires rather than what the diabetes assessment alone would. Where the eyes need treatment rather than screening, the ophthalmology schedule sets the pace.
Because type 2 diabetes is followed over decades rather than weeks, almost nobody stays for a course of treatment. The usual arrangement is a focused visit that confirms the diagnosis, establishes the type, completes overdue screening, sets the target and the medicine plan, and then hands a written schedule back to your own clinicians — with monitoring continued locally against the intervals set out on the monitoring page.
The tests a visit depends on are carried out by our endocrinology department, which holds subspecialty clinics for diabetes, thyroid disease, obesity and metabolic disease, and the pituitary, adrenal and gonadal axis, and for bone metabolism. The department uses scanned glucose monitoring, insulin pumps, retinal screening equipment, foot screening equipment, lipid testing and ultrasound. Results and monitoring downloads are filed so that they can be taken home to your own clinicians and read beside what they already hold.
Which records to send
Six groups of documents decide most of the assessment, and none of them needs translation beyond what our coordinators handle.
| What to send | What it answers |
|---|---|
| HbA1c results with dates, and any fasting or tolerance-test results | Whether the diagnosis was established properly, and whether the thresholds were documented rather than assumed |
| Current medicines with doses, including anything prescribed for another condition | Whether the plan matches your heart and kidney picture, and whether anything else is raising glucose |
| Kidney results — filtration rate and urine albumin — with dates | Whether the kidneys are affected, which changes the medicine choice as well as the follow-up |
| The report of the last eye screening, and the last foot examination | Whether anything has already been found, and whether either is overdue |
| Blood pressure readings taken at home, and the latest lipid panel | Where the rest of the risk sits, and whether the targets are being reached |
| Glucose logs, meter or monitor downloads, and a note of any hypoglycaemia | What the pattern actually is — including overnight and after meals, which no average shows |
| Dates of illness, steroid courses, surgery or hospital admission in the last year | Why a plan that had been steady may have drifted, and whether the cause is reversible |
Add the date the condition was diagnosed, whether the type was ever tested rather than assumed, your weight and waist history, and anything taken that was not prescribed — including supplements and herbal preparations, because these can interact with prescribed medicines. Photographs of clinic letters are acceptable to start with. Where screening has never been done, the opinion says so and names what to obtain locally first.
When travelling should wait
Postpone travel during an acute illness with fever; while vomiting or unable to keep fluids down; with a reading that will not come down or with ketones present; with an active foot infection, ulcer or a hot swollen foot; and in the weeks immediately after a heart event, a stroke or a major operation. Each of those is a state in which either the journey or the assessment carries real risk.
For everyone else, travelling with type 2 diabetes is routine with a few disciplines. Carry every medicine in hand luggage rather than in the hold, with more than the trip appears to need; keep insulin at the temperature the manufacturer specifies and never let it freeze; carry needles and lancets with a doctor's letter or a copy of the prescription, since the rules differ between countries; and carry carbohydrate and the means to treat a low in the cabin rather than in an overhead bag. Keep a copy of your latest results with their dates, and your sick-day rules, because those are what a clinician away from home asks for first.
Two practical points specific to the medicines. Anyone taking insulin or a sulfonylurea should carry carbohydrate and know how to treat a low on a long flight, and anyone taking an SGLT2 inhibitor should know that nausea, vomiting, abdominal pain or breathlessness needs assessment even where the glucose reading looks ordinary.
Time zones matter for insulin and for sulfonylureas rather than for anything else: how doses are shifted across a long-haul flight belongs in the written plan rather than in improvisation at the gate. Where a long flight crosses many zones, the plan is worth asking for before the tickets are booked.
Insurance and payment
Where you hold international health cover, coordinators confirm what is covered, what is excluded and which forms are required before arrival rather than after it. That matters more in this condition than it may appear, because an assessment that turns out to need eye screening, imaging or a monitoring period costs more than one that does not, and pre-authorisation should therefore cover the possibility rather than the most likely case.
Patients without suitable cover receive an itemised quotation and pay directly. Either way, costs are agreed in writing before travel. Where an insurer requires a specific form or a clinical letter, it is completed as part of the assessment rather than treated as a billable extra. Where a visa application needs a supporting letter or an estimate, coordinators issue it on request.
What happens after you go home
You leave with a written summary in English. For type 2 diabetes it covers the diagnosis and how it was established, the type and what settled it, the target agreed for you with the reasoning behind it rather than the number alone, every medicine with what it is for, the screening schedule with dates for the eyes, kidneys and feet, the hypoglycaemia plan where it applies, the sick-day rules, and what to measure to judge any change that was made.
Laboratory data and monitoring downloads are exported in standard formats so that your own clinicians continue the same series rather than beginning again from a single reading — which is the difference between a visit that changes the trajectory and one that produces a second, parallel set of records. Where a medicine was changed, the summary states what to measure to judge it and by when.
Our international department remains a written point of contact for questions about the opinion after you leave, and will correspond with your own doctor where that is useful. What it does not replace is local screening: the schedule is written so that it can be carried out where you live, and the dates are what make it happen.
Coming with someone
A companion is welcome, and in type 2 diabetes there is one specific reason to bring one. Where insulin, a pump or a glucose monitor is part of the visit, the teaching is hands-on: injection sites, rotation, how a monitor is applied and read, and what to do about a low. A second person who has seen that once is the difference between it being done correctly at home and it being approximated.
What we ask is that the companion be present at the consultation where the plan is set and the teaching happens, rather than only for the journey, because those are the parts that have to be reproduced later. Coordinators arrange accommodation near the department, and the companion leaves with the same written summary you do.
Where nobody can travel with you, the assessment runs the same way. The written summary is the safeguard: everything that would have been said to a companion is in it, including the schedule, the sick-day rules and the date of the next review.